
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1alpha, HIF2alpha, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma - Docwire News
Doc Wire News,
This article was originally published here J Exp Clin Cancer Res. 2021 Aug 12;40(1):254.